SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.620+3.2%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Druss who wrote (3870)9/23/1999 12:16:00 PM
From: Marconi   of 10293
 
Hello Druss: GUMM and study significance
You raise a superb point. Colds generally are not fatal (except those Soviet Premier colds a la Kosygin...). Infecting two halves of a sample population and treating both additionally with placebo as a control would make sense to have the basic form of a credible study (with appropriate blinding of all parameters to reduce observer bias). And repeating it several times would make further sense. Colds are largely once only for a particular strain of virus. Efficacy measured statistically over randomly selected strains would be important to generalize to colds in general. I have a few years grad level statistics in my background (and the degree), basically as a precaution to have a sense when people may be misapplying statistics (the majority of analyses) to knowingly avoid taking faulty stats too seriously; a form of pseudoscience easily perpetrated on the untrained.
Best regards,
m
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext